Clinical Trial Update: Neoadjuvant mFOLFOX6 Chemotherapy Combined With Anti-PD-1 Therapy in MSS/pMMR Locally Advanced Rectal Cancer (FIRM02 Study) [Phase 2]

View source ↗

Summary

A Phase 2 trial (FIRM02) is evaluating neoadjuvant mFOLFOX6 chemotherapy combined with an anti-PD-1 therapy in MSS/pMMR locally advanced rectal cancer; the stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Drugs mentioned

• Anti-PD-1 therapy
• MFOLFOX6

Snippet

Sponsor: Xinhua Hospital, Shanghai Jiao Tong University School of Medicine | Conditions: Rectal Cancer | Phase 2 | Status: NOT_YET_RECRUITING